Quantcast
Browsing latest articles
Browse All 15 View Live

Record Debt Sale Preps AbbVie For January Spin From Abbott Laboratories

Earlier this month, AbbVie (ABBV) completed a debt offering totaling $14.7 billion, making it the largest high grade offering in U.S history by over $1 billion and the largest of the year by nearly $5...

View Article


Abbott Board Approves AbbVie Spin

Abbott’s(ABT) spinoff of AbbVie(ABBV) passed its final hurdle yesterday as the Board approved the plan.  Shareholders of Abbott at the close of business on December 12 will receive, on January 1, one...

View Article


Final Stretch For Abbott Spin As Effective Date Nears, AbbVie Begins When...

On Friday, Abbott(ABT) announced the effectiveness of the registration statement for its AbbVie(ABBV) spin.  As we discussed previously, Abbott shareholders will get one AbbVie share for each Abbott...

View Article

For Whom The Dell Tolls- Newborn AbbVie To Replace Dell In S&P 100, To Join...

Some spinoffs are tiny, others are born big. AbbVie(ABBV) is a case of the latter. With a market cap of over $50 Billion, it begins life as a megacap when it spins off on January 2 from Abbott...

View Article

Morningstar Worries About AbbVie’s Reliance On Humira

It’s a few weeks old now, but with AbbVie’s(ABBV) spin from Abbott Laboratories(ABT) complete, we thought it worthwhile to mention this piece from Morningstar on AbbVie’s prospects.  No doubt,  the new...

View Article


AbbVie Spin From Abbott Complete Today – Discussion Thread

After long preparations, Humira manufacturer AbbVie(ABBV) has been spun off from former parent Abbott Laboratories(ABT). Abbott shareholders will wake up to find one share of AbbVie in their account...

View Article

Abbott and AbbVie- Spinoff Complete, Companies Begin To Walk Their Own Paths

On Wednesday, Abbott Laboratories(ABT) completed its spinoff of AbbVie(ABBV), and the two firms began their new, independent lives. As is often the case, as their first acts, each company issued a...

View Article

AbbVie Declares $.40 Dividend, Yield Stands At Over 4.6%

Not wasting any time, AbbVie(ABBV) declared a $.40 quarterly dividend on Friday, two days after its spin off from Abbott Laboratories(ABT).  At Friday’s closing price of $34.39, the stock yields 4.65%....

View Article


Bad Data Leads To Bad Conclusion In Seeking Alpha AbbVie/Abbott Analysis

AbbVie(ABBV) is one of the most massive spinoffs we’ve seen, so every piece of news or analysis is of interest to us. Hence it was with great interest that we noted that Seeking Alpha published...

View Article


Seeking Alpha Silently Updates Flawed Article On AbbVie, Fails To Note Heavy...

We wrote yesterday about a flawed article on SeekingAlpha about AbbVie(ABBV) and Abbott Laboratories(ABT) which contained information which was extremely erroneous(off by over $15 billion), and built a...

View Article

Oculus Innovative Sciences Plans To Spin Off Ruthigen

This has been a month where spinoff news has been dominated by a massive deal, the spin off of AbbVie(ABBV) by Abbott Laboratories(ABT). Yet, the vast majority of spinoffs involve tiny companies. We’ve...

View Article

AbbVie CFO: Big Acquisiton Not Prudent

AbbVie(ABBV) is a behemoth of a company following its spinoff from Abbott Laboratories(ABT), but it is a one-legged giant. The chorus of concern around the companies prospects has centered on its...

View Article

More AbbVie Inanity On Seeking Alpha With A Dose Of Penny Stock Promotion

Set a million monkeys loose with Yahoo Finance and a word processor, and what do you get? The answer, it would appear, is Seeking Alpha, a content farm with no particular editorial standards.  We wrote...

View Article


Can’t Decide Which One To Own? Cramer Picks Abbott Over AbbVie

Amidst our exhaustive coverage of the Abbott (ABT)/AbbVie (ABBV) separation, there has been no consensus as to which company is the ‘better’ one to own. Some people like AbbVie’s higher dividend yield...

View Article

13F Time: Bill Ackman Sells Alexander & Baldwin, Nelson Peltz Sells Kraft and...

13F season is always fun as it provides a rare (albeit delayed) glimpse into the thinking of large money managers and hedge funds. Of course, due to the significant time lag (~45 days), the exclusion...

View Article

Browsing latest articles
Browse All 15 View Live